Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pfizer
Luzerner Kantonsspital
Gustave Roussy, Cancer Campus, Grand Paris
Bolt Biotherapeutics, Inc.
Tempus AI
Actym Therapeutics, Inc.
Elevation Oncology
Inhibrx Biosciences, Inc
Novartis
Merck Sharp & Dohme LLC
Pfizer
Fate Therapeutics
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Tocagen Inc.
University of Wisconsin, Madison
CureOne
University of Pittsburgh
Celldex Therapeutics
University Health Network, Toronto
Masonic Cancer Center, University of Minnesota
Yale University
University of Wisconsin, Madison